(NP (NP (JJ Functional) (NN antagonism)) (PP (IN between) (NP-COOD (NP (NN vitamin) (NN D3)) (CC and) (NP (JJ retinoic) (NN acid)))) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP-COOD (NP (NN CD14)) (CC and) (NP (NN CD23))) (NN expression))) (PP-TMP (IN during) (NP (NP (JJ monocytic) (NN differentiation)) (PP (IN of) (NP (NN U-937) (NNS cells))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (CD 1,25) (NN alpha-Dihydroxicholecalciferol)) (PRN (-LRB- -LRB-) (NP (NN VitD3)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN RA)) (-RRB- -RRB-)))) (VP (VBP are) (NP-PRD (NP (JJ important) (NNS regulators)) (PP (IN of) (NP (NP (DT the) (NP-COOD (NP (NN proliferation)) (CC and) (NP (NN differentiation)))) (PP (IN of) (NP (JJ several) (NN cell) (NNS types))))))) (. .))
(S (NP-SBJ (DT This) (NN paper)) (VP (VBZ describes) (SBAR (WHADVP-24 (WRB how)) (S (NP-SBJ-COOD-25 (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT the) (JJ monocyte-macrophage) (NN Ag)) (, ,) (NP (NN CD14)) (, ,)))) (CC and) (NP (NP (NP (DT the) (JJ low) (NN affinity) (NN Fc) (NN receptor)) (PP (IN for) (NP (NN IgE)))) (, ,) (NP (NN CD23)) (, ,))) (VP (VBD were) (VP (ADVP (RB inversely)) (VBN regulated) (NP (-NONE- *-25)) (PP-TMP (IN during) (NP (NP (ADJP-COOD (ADJP (NP (NN VitD3-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ RA-induced))) (JJ monocytic) (NN differentiation)) (PP (IN of) (NP (JJ human) (NN U-937) (NNS monoblasts))))) (ADVP (-NONE- *T*-24))))))) (. .))
(S (NP-SBJ (NN PMA)) (VP (VBD induced) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP-COOD (CC both) (NP (NN CD14)) (CC and) (NP (NN CD23))) (NP-COOD (NP (NN mRNA)) (CC and) (NP (NN protein))))))) (. .))
(S (NP-SBJ (NP (NN Exposure)) (PP (TO to) (NP (NN VitD3)))) (ADVP-TMP (RB rapidly)) (VP (VBD induced) (NP (NP (DT the) (ADJP (FW de) (FW novo)) (NN expression)) (PP (IN of) (NP (NN CD14) (NP-COOD (NP (NN mRNA)) (CC and) (NP (NN protein))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN addition)) (PP (IN of) (NP (NN cycloheximide)))) (ADVP (RB completely)) (VP (VBD blocked) (NP (NP (DT the) (NN VitD3) (NN induction)) (PP (IN of) (NP (NN CD14) (NN mRNA) (NN expression)))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ (DT the) (NN induction)) (VP (VBD was) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (JJ ongoing) (NN protein) (NN synthesis)))))))))) (. .))
(S (SBAR (IN While) (S (NP-SBJ (-NONE- *-27)) (VP (VBG inducing) (NP (NN CD14) (NN expression))))) (, ,) (NP-SBJ-27 (NN VitD3)) (ADVP-TMP (RB concomitantly)) (VP (VBD suppressed) (NP (DT the) (ADJP-COOD (ADJP (JJ basal)) (, ,) (ADJP (NP (NN PMA-)) (ADJP (-NONE- *?*))) (, ,) (CC and) (ADJP (JJ RA-inducible))) (NN CD23) (NN expression)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner)))) (. .))
(S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN U-937) (NNS cells)) (VP (VBN induced) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN RA))))) (ADVP (RB strongly)) (VP (VBD increased) (NP (NP (PRP$ their) (NN expression)) (PP (IN of) (NP (NN CD23) (NP-COOD (NP (NN mRNA)) (CC and) (NP (NN protein)))))))) (, ,) (IN whereas) (S (NP-SBJ (PRP they)) (ADVP (RB completely)) (VP (VBD lacked) (NP (JJ detectable) (NN CD14) (NP-COOD (NP (NN cell) (NN surface)) (CC or) (NP (NN mRNA))) (NN expression)))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-28 (NP-COOD (NP (DT the) (ADJP (NP (NN VitD3-)) (ADJP (-NONE- *?*))) (NP (-NONE- *RNR*-29))) (CC and) (NP (DT the) (JJ PMA-induced) (NP (-NONE- *RNR*-29)))) (NP-29 (NN CD14) (NN expression))) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-28)) (PP (IN as) (NP (NP (DT a) (JJ temporal) (NN consequence)) (PP (IN of) (NP (DT the) (JJ RA-induced) (NN differentiation))))))) (. .))
(S (NP-SBJ (DT The) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBZ exists) (NP-PRD (NP (DT a) (JJ functional) (NN antagonism)) (PP (IN between) (NP-COOD (NP (NN VitD3)) (CC and) (NP (NN RA)))) (SBAR (WHNP-30 (WDT that)) (S (NP-SBJ (-NONE- *T*-30)) (VP (MD may) (VP (VB have) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ certain) (ADJP-COOD (ADJP (JJ immune)) (CC and) (ADJP (JJ inflammatory))) (NNS responses)))))) (PP (IN through) (NP (NP (PRP$ their) (JJ inverse) (NNS effects)) (PP (IN on) (NP (NP-COOD (NP (NN CD14)) (CC and) (NP (NN CD23))) (NN gene) (NN expression)))))))))))))) (. .))
